Pfizer: Candidiasis trials

The registry lists 15 Candidiasis studies with Pfizer as lead sponsor. 0 are open to participants now and 7 have results posted.

Phase 2 3Phase 3 6Phase 4 2No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United KingdomCompletedNCT01202253Results posted
• Voriconazole (Vfend) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)CompletedNCT01151085Results posted
• A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric PatientsTerminatedNCT01092832Phase 3Results posted
• An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune SystemTerminatedNCT00806351Phase 3Results posted
• An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To CandidaTerminatedNCT00805740Phase 3Results posted
• Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal InfectionCompletedNCT00739934Phase 2Results posted
• Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive CandidiasisCompletedNCT00496197Phase 4Results posted
• A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal InfectionsCompletedNCT00647907Phase 4
• A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.CompletedNCT00163111Phase 3
• The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive CandidiasisCompletedNCT00056368Phase 3
• The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC)CompletedNCT00041704Phase 2
• The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.CompletedNCT00037219Phase 2
• A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune SystemsCompletedNCT00002339Phase 3
• A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune SystemsCompletedNCT00002304Not applicable
• Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal TherapyCompletedNCT00002038Not applicable